Bionical Emas to further strengthen its position as a market leader in Early Access Programs and Clinical Trial Supply The Company will invest in global expansion and further specialised services to ...
Bionical Emas to further strengthen its position as a market leader in Early Access Programs and Clinical Trial Supply The Company will invest in global expansion and further specialised services ...
Bionical Emas to further strengthen its position as a market leader in Early Access Programs and Clinical Trial Supply The Company will invest in global expansion and further specialised services to ...
Kester Capital (“Kester”), a leading UK private equity investor focused on the life sciences and technology sectors, alongside a new senior management team, has acquired EMAS Pharma (“EMAS”) (“the ...
UK-based private equity firm Kester Capital has acquired EMAS Pharma, the clinical development division of Bionical Emas, ...
Willington, 09/12/2024 (informazione.it - comunicati stampa - economia) Bionical Emas to further strengthen its position as a market leader in Early Access Programs and Clinical Trial Supply ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback